Veradermics (MANE) Prepaid Assets (2024 - 2026)
Veradermics posted quarterly Prepaid Assets of $602000.0 for Q1 2026, up 96.09% on a QoQ basis from $307000.0 in Q4 2025.
Veradermics (MANE) has 3 years of Prepaid Assets data on file, last reported at $602000.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets changed N/A year-over-year to $602000.0; the trailing twelve-month figure through Mar 2026 stood at $602000.0 (changed N/A YoY), and the FY2025 full-year result was $307000.0, up 707.89% from the prior year.
- Prepaid Assets for Q1 2026 stood at $602000.0, up from $307000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $602000.0 in Q1 2026 and bottomed at $38000.0 in Q4 2024.
- The 3-year median for Prepaid Assets is $307000.0 (2025), against an average of $315666.7.
- Peak annual rise in Prepaid Assets reached 707.89% in 2025, while the deepest fall reached 707.89% in 2025.
- A 3-year view of Prepaid Assets shows it stood at $38000.0 in 2024, then jumped by 707.89% to $307000.0 in 2025, then soared by 96.09% to $602000.0 in 2026.
- The last three Prepaid Assets figures came in at $602000.0 (Q1 2026), $307000.0 (Q4 2025), and $38000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Veradermics | 2.29 Bn | 2.29 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 602,000.00 |
| Dec 31, 2025 | 307,000.00 |
| Dec 31, 2024 | 38,000.00 |